Table 3.
Condition | Specific/additional complications | N = 35 | Age | Comorbidity | Identification method | Treatment | Outcome | Study |
---|---|---|---|---|---|---|---|---|
Myocarditis N = 29 |
– | 1 M | 38 days | None | Elevated Troponin and CMR | NR | Recovered | Del Barba et al. [23] |
1 F | 2 months | None | Elevated Troponin T and TTE | Antibiotics, IVg | Recovered | Giacomet et al. [23] | ||
1 M | 16 years | None | Elevated Troponin I and ECG | Antiviral, aspirin, HCQ, NSAID | Recovered | Genecchi et al. [25] | ||
20 (10 M, 10F) | 2.9–15 years | None | Elevated Troponin, ECG and TTE | Dobutamine, epinephrine, HFOT, IL-1 receptor antagonist, IMV, inotropes, intubation, IVIg, milrinone, NIV, norepinephrine, steroids, tocilizumab | Recovered | Grimaud et al. [27] | ||
1 M | 8 years | None | Elevated Troponin T, TTE and CMR | Antibiotics, anticoagulant, dobutamine, IVIg, milrinone, oxygen support, tocilizumab | Recovered | Oberweis et al. [32] | ||
Kawasaki disease like symptoms | 4 | 6–12 years | None | Elevated Troponin I and/or CMR/TTE | Aspirin, HFOT, IMV, IVIg, steroids, vasoactive agents, volume expanders | Recovered | Blondiaux et al. [20] | |
1 M | 5 years | None | TTE | Antibiotics, ACEi, diuretics, inotropic support, IVIg, HFOT, steroids | Recovered | Rauf et al. [34] | ||
Kawasaki disease like symptoms only N = 1 |
– | 1 F | 11 years | None | Elevated Troponin and TTE | Antivirals, convalescent plasma, enoxaparin, IVIg, milrinone, norepinephrine, vitamin K, steroids, tocilizumab, vitamin K | Recovered | Greene et al. [26] |
Other types of cardiac Injury N = 5 |
– | 1 M | 2 months | None | Elevated Troponin | IFN inhalation | Recovered | Cai et al. [21] |
1 M | 16 years | Non-CVDa | Elevated Troponin T and TTE | Epinephrine, hydrocortisone, HCQ, milrinone, IV fluids | Recovered | Latimer et al. [30] | ||
MODS | 2 (F,M) | 10, 14 months | Non-CVDa | Not specified | Ribavirin, blood purification IFN inhalation, IMV, IV, IVIg, Methylprednisone, O2 support | 1 Died 1 Recovered |
Cai et al. [21] | |
RV Failure and cardiogenic shock | 1 | 6 months | Non-CVDa | Elevated Troponin I, ECG and TTE | Antibiotics, anticoagulants, HCQ, IMV, milirinone, norepinephrine, tocilizumab | Recovered | Rodriguez-Gonzalez et al. [33] |
ACEi: angiotensin converting enzyme inhibitors; CVD: Cardiovascular diseases; ECMO: Extra Corporeal Membrane Oxygenation; HCQ: Hydroxychloroquine, HFOT: High Flow Oxygen Therapy; N: Number of patients; NR: Not reported; CMR: Cardiovascular Magnetic Resonance Imaging; Therapy; CT: Computed Tomography; ECG: Electrocardiography; ECHO: echocardiogram; IVIg: Intravenous Immunoglobulin; MODS: Multisystem Organ Dysfunction Syndrome; NIV: Non-Invasive Ventilation; NSAID: Non-Steroidal Anti Inflammatory Drugs; N: Number of patients; NR: Not reported; RV: Right Ventricle; TTE: Transthoracic Echocardiography.
All comorbidities are listed in Supplementary Table 3.